J&J plots path ahead for 2018
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Rolling out “insight-led” innovation, “rapid” e-commerce expansion, and a global relaunch of its Baby Care franchise will help Johnson & Johnson’s (J&J’s) Consumer business to drive growth in 2018, according to the firm’s chief executive officer Alex Gorsky.
You may also be interested in...
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.
J&J's Supplement Step With Zarbees Helps Drive A Leap For Consumer Health Growth
Supplement brand being marketed to compete with OTC drugs, including J&J's own brands, in cough and cold and other categories helped J&J overall consumer health sales grow 9.7% to $440m in Q3. Oral care brands showed 3.2% worldwide growth to $384m, benefiting from recent launch of chewable Listerine Ready! Tabs.